Skip to main content

Table 2 Secondary and safety outcome measures

From: High-flow oxygen via nasal cannulae in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis

Outcome or subgroup

 

Participants

Effect estimate

(95% CI)

I 2 (UCI)

Studies

Intervention

Control

Patient tolerance [26, 30]

2

n = 126

n = 227

SMD − 0.63

(− 1.11, − 0.15)

54%

Intubation [26, 27, 29, 31, 34]

5

113/764

176/841

RR 0.85

(0.70, 1.04)

0% (0%, 74%)

Cardio-respiratory arrest [26,27,28, 34]

3

5/341

13/207

RR 0.65

(0.26, 1.62)

0%

(0%, 87%)

PaO2:FiO2 a [26, 27]

2

n = 520

n = 623

MD − 53.34

(− 71.95, − 34.72)

61%

pHa [26, 27]

2

n = 520

n = 623

MD 0.01 (0.00, 0.01)

36%

PaCO2 a [26, 27]

2

n = 520

n = 623

MD − 0.66

(− 1.47, 0.16)

67%

  1. HFNC high-flow nasal cannulae, I 2 I-squared, UCI uncertainty intervals
  2. aRating at 6–12 h post-randomization